Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
27.98
+0.02 (0.07%)
Jul 23, 2024, 4:30 PM EDT - Market closed

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $2.26M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $874.00K with 83.61% year-over-year growth. In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M.

Revenue (ttm)
$2.26M
Revenue Growth
-20.15%
P/S Ratio
364.17
Revenue / Employee
$42,547
Employees
53
Market Cap
821.20M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
Phibro Animal Health 999.56M
Evolus 219.70M
Aurinia Pharmaceuticals 191.41M
OrthoPediatrics 161.83M
Simulations Plus 66.98M
Abivax 5.13M
Revenue Rankings